[18F]AlF-NOTA-PCP2 PET/CT to Assess PD-L1 Status in Head and Neck Cancer
Year: 2025
Type: article
Language: en
Topic: Cancer Immunotherapy and Biomarkers
Authors and affiliations:
raw_author_name: Yong Wang
raw_affiliation_strings: Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, New York, NY
Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
raw_author_name: Zhiguo Liu
raw_affiliation_strings: Department of PET/CT Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
raw_author_name: Yang Li
raw_affiliation_strings: Department of Molecular Imaging, Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong, China
raw_author_name: Kewen He
raw_affiliation_strings: Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
raw_author_name: Xingchen Ding
raw_affiliation_strings: Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
raw_author_name: Kai Teng
raw_affiliation_strings: Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
raw_author_name: Dongfang Meng
raw_affiliation_strings: Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
raw_author_name: Jian Shi
raw_affiliation_strings: Department of PET/CT Center, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
raw_author_name: Shijie Wang
raw_affiliation_strings: Department of Molecular Imaging, Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong, China
raw_author_name: Bohan Zhang
raw_affiliation_strings: Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, New York, NY
raw_author_name: Zhe-sheng Chen
raw_affiliation_strings: Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, New York, NY
raw_author_name: Jinming Yu
raw_affiliation_strings: Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China
raw_author_name: Man Hu
raw_affiliation_strings: Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China